An article discusses the rise of BeiGene, Ltd. and other biotech stocks in 2025, highlighting the impact of aging populations and AI breakthroughs on healthcare. With BeiGene's strong financial performance and hedge fund interest, the stock has surged 50.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing